Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
After finishing at $1.08 in the prior trading day, Alzamend Neuro Inc (NASDAQ: ALZN) closed at $1.01, down -6.48%. In other words, the price has decreased by -$6.48 from its previous closing price. On the day, 14.33 million shares were traded.
Ratios:
Our goal is to gain a better understanding of ALZN by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.80 and its Current Ratio is at 3.80. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Ascendiant Capital Markets on October 01, 2021, initiated with a Buy rating and assigned the stock a target price of $8.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 06 ’24 when AULT MILTON C III bought 75 shares for $2.75 per share. The transaction valued at 206 led to the insider holds 77,268 shares of the business.
AULT MILTON C III bought 25 shares of ALZN for $93 on Jul 31 ’24. The Director now owns 77,193 shares after completing the transaction at $3.74 per share. On Apr 19 ’24, another insider, AULT MILTON C III, who serves as the Director of the company, bought 1,000 shares for $0.69 each. As a result, the insider paid 688 and bolstered with 771,699 shares of the company.
Stock Price History:
Over the past 52 weeks, ALZN has reached a high of $15.06, while it has fallen to a 52-week low of $1.05. The 50-Day Moving Average of the stock is -13.45%, while the 200-Day Moving Average is calculated to be -62.09%.
Shares Statistics:
A total of 5.23M shares are outstanding, with a floating share count of 5.23M. Insiders hold about 3.75% of the company’s shares, while institutions hold 2.09% stake in the company.
